Compare CVM & ZENV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVM | ZENV |
|---|---|---|
| Founded | 1983 | 2005 |
| Country | United States | Brazil |
| Employees | N/A | 956 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.1M | 56.2M |
| IPO Year | 1987 | 2021 |
| Metric | CVM | ZENV |
|---|---|---|
| Price | $4.98 | $1.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 63.5K | 29.8K |
| Earning Date | 01-12-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $201,426,369.00 |
| Revenue This Year | N/A | $12.75 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 24.80 |
| 52 Week Low | $1.98 | $0.94 |
| 52 Week High | $32.70 | $3.03 |
| Indicator | CVM | ZENV |
|---|---|---|
| Relative Strength Index (RSI) | 29.48 | 29.79 |
| Support Level | $6.20 | $0.94 |
| Resistance Level | $6.75 | $1.27 |
| Average True Range (ATR) | 0.52 | 0.08 |
| MACD | -0.09 | -0.01 |
| Stochastic Oscillator | 7.78 | 36.36 |
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
Zenvia Inc provides a platform that enables companies to create journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.